GILEAD SCIENCES, INC. Proceeds from (Payments to) Noncontrolling Interests
GILEAD SCIENCES, INC. (GILD) reported Proceeds from (Payments to) Noncontrolling Interests of -$90.00 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsToMinorityShareholders · last filed 2017-02-27
- GILEAD SCIENCES, INC. proceeds from (payments to) noncontrolling interests for the quarter ending 2016-12-31 was -$7.00M, a 114.89% decline year-over-year.
- GILEAD SCIENCES, INC. proceeds from (payments to) noncontrolling interests for the quarter ending 2016-09-30 was -$82.00M, a 142.93% decline year-over-year.
- GILEAD SCIENCES, INC. proceeds from (payments to) noncontrolling interests for the quarter ending 2016-06-30 was -$42.00M.
- GILEAD SCIENCES, INC. proceeds from (payments to) noncontrolling interests for the quarter ending 2016-03-31 was $41.00M, a 105.00% increase year-over-year.
- GILEAD SCIENCES, INC. proceeds from (payments to) noncontrolling interests for fiscal 2016 was -$90.00M, a 147.87% decline from fiscal 2015.
- GILEAD SCIENCES, INC. proceeds from (payments to) noncontrolling interests for fiscal 2015 was $188.00M, a 437.14% increase from fiscal 2014.
- GILEAD SCIENCES, INC. proceeds from (payments to) noncontrolling interests for fiscal 2014 was $35.00M, a 76.97% decline from fiscal 2013.
- GILEAD SCIENCES, INC. proceeds from (payments to) noncontrolling interests for fiscal 2013 was $152.00M, a 16.03% increase from fiscal 2012.
| Period end | Proceeds from (Payments to) Noncontrolling Interests 3 month | Proceeds from (Payments to) Noncontrolling Interests 3 month as first filed | Proceeds from (Payments to) Noncontrolling Interests 6 month | Proceeds from (Payments to) Noncontrolling Interests 6 month as first filed | Proceeds from (Payments to) Noncontrolling Interests 9 month | Proceeds from (Payments to) Noncontrolling Interests 9 month as first filed | Proceeds from (Payments to) Noncontrolling Interests 12 month | Proceeds from (Payments to) Noncontrolling Interests 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$89.00M derived: sum of 2 quarters · filed 2017-02-27 | -$131.00M derived: sum of 3 quarters · filed 2017-02-27 | -$90.00M 10-K · filed 2017-02-27 | ||||
| 2016-09-30 | -$82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$124.00M derived: sum of 2 quarters · filed 2016-11-07 | -$83.00M 10-Q · filed 2016-11-07 | -$36.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2016-06-30 | -$42.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$1.00M 10-Q · filed 2016-08-05 | $46.00M derived: sum of 3 quarters · filed 2017-02-27 | $237.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2016-03-31 | $41.00M 10-Q · filed 2016-05-06 | $88.00M derived: sum of 2 quarters · filed 2017-02-27 | $279.00M derived: sum of 3 quarters · filed 2017-02-27 | $209.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $238.00M derived: sum of 2 quarters · filed 2017-02-27 | $168.00M derived: sum of 3 quarters · filed 2017-02-27 | $188.00M 10-K · filed 2017-02-27 | ||||
| 2015-09-30 | $191.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $121.00M derived: sum of 2 quarters · filed 2016-11-07 | $141.00M 10-Q · filed 2016-11-07 | $237.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | -$70.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$50.00M 10-Q · filed 2016-08-05 | $46.00M derived: sum of 3 quarters · filed 2017-02-27 | $12.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $20.00M 10-Q · filed 2016-05-06 | $116.00M derived: sum of 2 quarters · filed 2017-02-27 | $82.00M derived: sum of 3 quarters · filed 2017-02-27 | $111.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $96.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $62.00M derived: sum of 2 quarters · filed 2017-02-27 | $91.00M derived: sum of 3 quarters · filed 2017-02-27 | $35.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | -$34.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$5.00M derived: sum of 2 quarters · filed 2015-11-04 | -$61.00M 10-Q · filed 2015-11-04 | -$61.10M 10-Q · filed 2014-11-05 | $10.41M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $29.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$27.00M 10-Q · filed 2015-08-05 | -$26.79M 10-Q · filed 2014-08-04 | $44.41M derived: sum of 3 quarters · filed 2016-02-24 | $105.28M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | -$56.00M 10-Q · filed 2015-05-08 | -$55.74M 10-Q · filed 2014-05-07 | $15.41M derived: sum of 2 quarters · filed 2016-02-24 | $76.28M derived: sum of 3 quarters · filed 2016-02-24 | $92.41M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $71.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $132.28M derived: sum of 2 quarters · filed 2016-02-24 | $148.41M derived: sum of 3 quarters · filed 2016-02-24 | $152.00M 10-K · filed 2016-02-24 | $151.83M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $60.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $77.00M derived: sum of 2 quarters · filed 2014-11-05 | $80.59M 10-Q · filed 2014-11-05 | $179.17M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $16.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $19.72M 10-Q · filed 2014-08-04 | $118.30M derived: sum of 3 quarters · filed 2015-02-25 | $188.03M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $3.59M 10-Q · filed 2014-05-07 | $102.18M derived: sum of 2 quarters · filed 2015-02-25 | $171.90M derived: sum of 3 quarters · filed 2015-02-25 | $208.18M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $98.59M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $168.31M derived: sum of 2 quarters · filed 2015-02-25 | $204.59M derived: sum of 3 quarters · filed 2015-02-25 | $131.00M 10-K · filed 2015-02-25 | $130.60M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $69.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $106.01M derived: sum of 2 quarters · filed 2013-10-31 | $32.41M 10-Q · filed 2013-10-31 | $47.85M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $36.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$37.31M 10-Q · filed 2013-08-01 | -$21.87M derived: sum of 3 quarters · filed 2014-02-25 | -$66.33M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$73.59M 10-Q · filed 2013-05-08 | -$58.16M derived: sum of 2 quarters · filed 2014-02-25 | -$102.62M derived: sum of 3 quarters · filed 2014-02-25 | -$163.47M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $15.44M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$29.02M derived: sum of 2 quarters · filed 2014-02-25 | -$89.88M derived: sum of 3 quarters · filed 2014-02-25 | -$115.04M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | -$44.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$105.31M derived: sum of 2 quarters · filed 2012-11-06 | -$130.47M 10-Q · filed 2012-11-06 | -$41.77M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | -$60.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | -$86.02M 10-Q · filed 2012-08-01 | $2.69M derived: sum of 3 quarters · filed 2013-02-27 | $40.35M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | -$25.16M 10-Q · filed 2012-05-04 | $63.54M derived: sum of 2 quarters · filed 2013-02-27 | $101.21M derived: sum of 3 quarters · filed 2013-02-27 | $80.97M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $88.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $126.37M derived: sum of 2 quarters · filed 2013-02-27 | $106.13M derived: sum of 3 quarters · filed 2013-02-27 | $131.52M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $37.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $17.43M derived: sum of 2 quarters · filed 2011-11-04 | $42.82M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | -$20.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $5.15M 10-Q · filed 2011-08-05 | ||||||
| 2010-03-31 | $25.39M 10-Q · filed 2011-05-09 | |||||||
| 2009-12-31 | -$44.75M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |